AzTrials
AzTrials

FallNCT05090774

Integrating Fall Prevention Balance Exercises Into a Program for Older Adults With Peripheral Artery Disease (PAD): A Mixed Methods Feasibility Study

A study testing Adapted Otago Exercise Program (OEP) in people with Fall and Fall Injury, run by University of Minnesota at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overarching objective of this study is to improve fall prevention efforts in community-dwelling older adults with peripheral artery disease (PAD) to reduce falls. To accomplish this, the investigators will conduct a feasibility study and pilot the addition of a balance exercise component to existing supervised… Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Fall, Fall Injury, Peripheral Artery Disease
What is being tested?
Adapted Otago Exercise Program (OEP)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
7 Oct 2021to 1 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Enrolled in supervised exercise therapy (SET)
  • One or more fall risk factors as determined by CDC STEADI fall risk screener
  • One or more falls in the last year
  • Unsteadiness when standing or walking
  • Worries about falling
  • Have symptomatic peripheral artery disease (PAD) with objective diagnosis (ABI less than or equal to 0.90 or previous revascularization)

Who cannot join

  • Formal diagnosis of neurocognitive impairment or <3 on Callahan 6-Item Screener
  • Current uncontrolled vestibular dysfunction (e.g. Meniere's Disease, benign paroxysmal positional vertigo)
  • Participants who self-report the following symptoms will require clearance from a primary provider (as guided by the Exercise and
  • Screening for You Questionnaire):
  • Pain, tightness or pressure in chest during physical activity (walking, climbing stairs, household chores, similar activities) that have not been checked and/ or treated by a healthcare provider
  • Current dizziness that have not been checked and/ or treated by a healthcare provider
  • Current, frequent falls that have not been checked and/ or treated by a healthcare provider
  • Other clinically significant disease that is, in the opinion of the study team, not stabilized or may otherwise confound the results of the study

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Minnesota

    Minneapolis, Minnesota, 55455

Other trials in United States

About this study

The overarching objective of this study is to improve fall prevention efforts in community-dwelling older adults with peripheral artery disease (PAD) to reduce falls. To accomplish this, the investigators will conduct a feasibility study and pilot the addition of a balance exercise component to existing supervised exercise therapy (SET) programs for PAD. This intervention may be an effective way to help older adults with PAD self-manage their leg pain and walking impairments as well as fall risk. The long-term goal of this research is to reduce morbidity and mortality associated with falls in older adults with symptomatic PAD through the development and evaluation of a balance intervention component implemented within existing exercise programs. Findings from this research may also be translated to the implementation of disease management programs for other chronic conditions associated with fall risk. The rationale for this research is to determine improve disease-specific, comprehensive and fall prevention strategies for older adults with PAD.

Read the detailed description

Falls are a growing public health concern as the proportion of aging adults will continue to increase in the coming years and the prevalence of falls is high. Older adults with PAD have previously demonstrated impaired static balance, higher prevalence of history of stumbling/unsteadiness (41%) and falling (26%), and abnormal balance using computerized dynamic posturography compared to non-PAD controls. Adults with symptomatic PAD also demonstrate LE weakness and gait deficiencies due to impaired muscle power and biomechanics. While still unspecified, muscle weakness and ischemic neuropathy could partially explain the etiology for impaired balance in those with PAD. Other potential associations with increased fall risk in PAD may include claudication, limited physical activity, and poor LE function. Through expansion of disease-specific knowledge related to fall prevention interventions in older adults with PAD, healthcare providers may find that targeted balance screening and interventions to improve balance and strength are essential to disease management and the prevention of disability. The proposed study is innovative as it is the first balance intervention study in PAD and uses an explanatory sequential mixed methods design. Given the known associations between PAD and balance, in addition to morbidity and mortality associated with falls in the general population of older adults, the contribution of this knowledge is unique in that it will improve understanding of interventional study designs, leading to future revisions in prevention strategies for this sub-group.

Findings from a recent systematic review of fall prevention interventions for community-dwelling older adults with chronic conditions suggest that the stage of intervention development primarily lies within efficacy-based RCTs that focus on internal validity, which limits the generalizability of these intervention effects for varying contexts. Most of these interventional studies did not report detail related to adoption and maintenance, such as recruitment of participants from the target populations and intervention adoption by staff, which are critical to understanding how to implement these interventions in clinical settings. There was also a lack of qualitative research methods use across the studies, which limits the understanding of participants' acceptability and perceived intervention effects. Most of these trials were conducted in controlled research setting environments adjacent to, but not integrated within, clinical practice settings without staff involvement, which impacts the adoption of these programs. While all of the studies in the review included targeted, individuals, and moderately challenging balance exercises (some with additional strength and aerobic training components), the dosing of balance exercises was not sufficient to meet the exercise duration recommendations over the intervention period. Due to the stage of development, it is challenging to evaluate the long-term implementation and public impact of these interventions with delivery performed by clinicians and community partners who have direct contact with this target population. Despite the inextricable relationships between fall risk and PAD, self- management interventions for fall risk and PAD are currently not integrated into PAD treatment. Often, interventions for self-management of chronic conditions and fall prevention are delivered separately. Given the complexity, time, and effort required for PAD self-management programs, a separate stand- alone program for fall prevention exercises is unlikely due to its added burden on patients. Thus, there is a need to explore the feasibility of integrating evidence- based fall prevention exercises into existing PAD programs. Some researchers have investigated the integration of rehabilitation programs and fall prevention in patients with chronic obstructive pulmonary disease, where balance exercises were delivered as part of either outpatient and inpatient pulmonary rehab. Although balance training has not been implemented as a standard treatment for PAD subgroups, there is potential for its addition to established PAD programs. Many older adults with PAD participate in outpatient supervised exercise therapy (SET) walking programs, which are the most effective non-invasive method to mitigate claudication and improve walking function in adults with PAD. In addition to mitigating fall risk, the combined balance training within SET programs also has potential to improve patient outcomes. Balance training could be an adjunct to the SET standard of care, which is designed to improve claudication symptoms and address walking function. Although intermittent treadmill walking is the optimal mode to maximize benefits from exercise training for PAD, it is often contraindicated or refused due to poor balance. As walking demands adequate balance, LE strength, and endurance, individuals with poor postural control may benefit from improving their balance prior to or during the initiation of walking exercise to manage their vascular disease. Thus, the simultaneous learning and mastering of balance exercises to reduce fall risk may enable successful participation in treadmill walking, thus maximizing the benefits gained from SET.

Being tested
Adapted Otago Exercise Program (OEP)
Medical subject headings
Peripheral Arterial Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Adapted Otago Exercise Program (OEP)Behavioural

    A modified version of the 8- week evidence-based Otago Exercise Program (OEP), adapted for integration into supervised exercise therapy (SET). The OEP exercises will include 12 static and dynamic standing balance movements (knee bends, backwards walking, walking and turning, sideways walking, tandem stance, tandem walk, one leg stand, heel walking, toe walking, heel-toe walking backwards, sit to stand, stair walking). The OEP also contains additional behavior change techniques embedded within the intervention protocol (i.e. feedback on behavior, self-monitoring of behavior, biofeedback).

Study groups in NCT05090774
Study groupRoleWhat they receive
Supervised Exercise Therapy (SET) Plus Balance ExercisesExperimentalIntervention meetings surrounding supervised exercise therapy (SET) with the addition of the adapted Otago Exercise Program (OEP) will occur individually with participants in a 1:1 format once per week for 30 minutes over 8 weeks. Additionally, participants will be encouraged to practice exercises at home at least 2 additional days between intervention meetings using visual handouts (up to 7 times/week total, approximately 140 minutes/week).
Receives: Behavioral: Adapted Otago Exercise Program (OEP)
Supervised Exercise Therapy (SET) OnlyNo interventionIntervention meetings surrounding supervised exercise therapy (SET) will occur individually with participants in a 1:1 format once per week for 30 minutes over 8 weeks. Additionally, participants will be encouraged to practice exercises at home at least 2 additional days between intervention meetings using visual handouts (up to 7 times/week total, approximately 140 minutes/week).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Mini-Balance Evaluation Systems Test Score

    The Mini-Balance Evaluation Systems Test consists of 14 items with total scores ranging from 0-28. Higher scores indicate better balance performance. Balance will be evaluated pre- and post-intervention.

    Measured: Baseline and 8 weeks

Secondary outcomes (11)
  1. Percent Target Recruitment

    The percent of target recruitment achieved will be assessed pre- and post-intervention as a measure of demand.

    Measured: Baseline and 8 weeks

  2. Rate of Participants Enrolled Per Month

    Enrollment rates per month will be reported as participants per month as a measure of demand.

    Measured: 8 weeks

  3. Percent of Participants that Complete 8-Week Intervention

    The percent of participants that complete the 8-week intervention out of total participants will be reported as a measure of retention and acceptance.

    Measured: 8 weeks

  4. Satisfaction Questionnaire Score

    Satisfaction with and evaluation of the program will be assessed via a 5-item Likert scale ranging from 'Strongly Disagree' to 'Strongly Agree', where higher scores indicate greater satisfaction.

    Measured: 8 weeks

  5. Interventions Attended

    Attendance will be measured as the average number of intervention sessions attended across participants and reported as a number of sessions.

    Measured: 8 weeks

  6. Adherence to Home-Based Balance Exercises

    Intervention fidelity will be measured via adherence to home-based balance exercises and reported as the average number of days that participants exercised at home per week. Adherence will be assessed weekly via an exercise tracker.

    Measured: 8 weeks

  7. Change in Timed Up and Go (TUG) Test Score

    The TUG test measures the time it takes to stand from a chair, walk 10 feet, turn around, walk to the chair, and sit and will be reported in seconds. TUG test will be assessed pre- and post-intervention.

    Measured: Baseline and 8 weeks

  8. Change in Short Performance Physical Battery (SPPB) Score

    The SPPB is reported as a score on 5 balance, strength, and walking tests that evaluate lower extremity function. The range of summed scores is 0-12, where 12 indicates better lower extremity function. The SPPB will be assessed pre- and post-intervention.

    Measured: Baseline and 8 weeks

  9. Fall Rates Per Month

    The average monthly rate of self-reported falls over the intervention period will be reported as falls per month.

    Measured: 8 weeks

  10. Change in Falls Efficacy Scale-International Score

    The Falls Efficacy scale assesses levels of concern for falling while performing 16 different common tasks with the sum of scores ranging from 0-100, where 100 indicates [INSERT]. The Falls Efficacy Scale will be assessed pre- and post-intervention.

    Measured: Baseline and 8 weeks

  11. Change in Life-Space Assessment (LSA) Score

    The LSA is reported as the average weekly frequency and independence of life-space mobility, with a sum of scores ranging from 0-120, where higher scores indicate greater mobility. LSA will be measured pre- and post-intervention.

    Measured: Baseline and 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2021
  2. Study start7 Oct 2021
  3. Primary completion1 Mar 2023
  4. Study completion1 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05090774
Sponsor's protocol ID
SON-2021-30171
Status last verified
Apr 2023
First submitted
6 Oct 2021
Last updated
7 Apr 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Adapted Otago Exercise Program (OEP) in people with Fall and Fall Injury, run by University of Minnesota at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Mini-Balance Evaluation Systems Test Score (time frame: Baseline and 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in